Clinical Trials Browser

Terminated × Lymphoma, T-Cell × Lenalidomide × Clear all

Hodgkin Disease, Multiple Myeloma, Lymphoma, T-Cell

NCT00655668 2019-11-25

EXPECT

Phase 2 Terminated

54 enrolled 13 charts

Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, T-Cell

NCT00704691 2012-04-20

Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas

Phase EARLY_PHASE1 Terminated

1 enrolled

LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Leukemia-Lymphoma, Adult T-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

RID

EXPECT

Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas